Park Square is pleased to announce the placement of Jamie Lewis as Chief Commercial Officer at Inflammatix. Inflammatix is a pioneering...
Park Square has placed Frederick Beddingfield III, M.D., Ph.D., as Chief Executive Officer at Rubedo Life Sciences.
Park Square has placed Nelson Azoulay as Senior Vice President of Strategy and Business Development at Flagship Pioneering. In this role,...
We are often asked by private equity SaaS investors how we would categorize the current state of the market and what factors contribute...
Park Square has placed Doug Frantz as vice chancellor for innovation and commercialization at Washington University in St. Louis.
Park Square has placed Alexandra Joseph, Ph.D., as Chief Scientific Officer at Photys Therapeutics.
Park Square is pleased to announce the placement of Julia Tran at Xaira Therapeutics, where she will lead the People and Culture...
Park Square has placed Bill Colston, Ph.D., as Chief Executive Officer at CS Genetics.
Park Square is pleased to announce the placement of Brandi Simpson as Senior Vice President, Business Development at Switch Therapeutics....
Park Square is pleased to announce the placement of Dr. Lúcia G. Lohmann as President of Missouri Botanical Garden.
Park Square has placed Glenn Reicin as Chief Financial Officer at Eccogene.
Park Square is pleased to announce the placement of Dr. Tim Sullivan as Chief Business Officer at Infinimmune.
Park Square is pleased to announce the placement of Jose Trevejo, M.D., Ph.D. as Chief Medical Officer and Bigyan Bista, Ph.D. as Senior...
Park Square is pleased to announce the placement of Brian Hotchkiss as Chief Business Officer at Bexorg, Inc. A spinout of Nenad Sestan’s...
Park Square is pleased to announce the placement of Richard Gregory, Ph.D., as the next Chair of the Department of Molecular, Cell &...
Park Square is pleased to announce the placement of Stephen Byrnes as Chief Sales Officer at Valant. Valant is a private, PE-backed...